Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease

Soumya Mukherjee, Nicolas R. Barthélemy, Taraneh Atri, Yan Li, Daniel Yen, Yingxin He, Reid Coyle, Vitaliy Ovod, Erin E. Franklin, Chengjie Xiong, Guoqiao Wang, Jinbin Xu, Huifangjie Farsad, Catherine J. Mummery, Colin L. Masters, Raquel Sanchez-Valle, Mario Masellis, Ging-Yuek Robin Hsiung, Serge Guthier, James J. Lah, Sarah B. Berman, Erik D. Roberson, Ghulam Surti, Lawrence S. Honig, Roger Clarnette, Paolo Vitali, John Ringman, Thomas D. Bird, William S. Brooks, Nick C. Fox, Kazushi Suzuki, Sandra E. Black, Johannes Levin, Martin R. Farlow, Jasmeer Chhatwal, Neelum T. Aggarwal, Mathias Jucker, Matthew P. Frosch, Julia K. Kofler, Charles White, C. Dirk Keene, Jie Chen, Jonathan Glass, Marla Gearing, Natalie S. Ryan, David Aguillón, Charlene Supnet-Bell, Brian A. Gordon, Tammie L.S. Benzinger, John Sims, Roy Yaari, Tobias Bittner, Gregory Klein, Paul Delmar, John C Morris, Jorge Llibre-Guerra, David B. Clifford, Celeste M. Karch, Eric McDade, Richard J. Perrin, Randall J. Bateman, Unknown, Unknown

Open source

DOI: 10.64898/2026.09.22.26363432
Published: 2026-09-29
Container: Not recorded
Publisher: openRxiv
Open access: unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
cautionPublication version: Identified as a preprint; peer review and later versions may change the record. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.09.22.26363432,
title = {Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease},
author = {Soumya Mukherjee and Nicolas R. Barthélemy and Taraneh Atri and Yan Li and Daniel Yen and Yingxin He and Reid Coyle and Vitaliy Ovod and Erin E. Franklin and Chengjie Xiong and Guoqiao Wang and Jinbin Xu and Huifangjie Farsad and Catherine J. Mummery and Colin L. Masters and Raquel Sanchez-Valle and Mario Masellis and Ging-Yuek Robin Hsiung and Serge Guthier and James J. Lah and Sarah B. Berman and Erik D. Roberson and Ghulam Surti and Lawrence S. Honig and Roger Clarnette and Paolo Vitali and John Ringman and Thomas D. Bird and William S. Brooks and Nick C. Fox and Kazushi Suzuki and Sandra E. Black and Johannes Levin and Martin R. Farlow and Jasmeer Chhatwal and Neelum T. Aggarwal and Mathias Jucker and Matthew P. Frosch and Julia K. Kofler and Charles White and C. Dirk Keene and Jie Chen and Jonathan Glass and Marla Gearing and Natalie S. Ryan and David Aguillón and Charlene Supnet-Bell and Brian A. Gordon and Tammie L.S. Benzinger and John Sims and Roy Yaari and Tobias Bittner and Gregory Klein and Paul Delmar and John C Morris and Jorge Llibre-Guerra and David B. Clifford and Celeste M. Karch and Eric McDade and Richard J. Perrin and Randall J. Bateman and Unknown and Unknown},
year = {2026},
doi = {10.64898/2026.09.22.26363432},
url = {https://doi.org/10.64898/2026.09.22.26363432}
}

RIS

TY  - JOUR
TI  - Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease
AU  - Soumya Mukherjee
AU  - Nicolas R. Barthélemy
AU  - Taraneh Atri
AU  - Yan Li
AU  - Daniel Yen
AU  - Yingxin He
AU  - Reid Coyle
AU  - Vitaliy Ovod
AU  - Erin E. Franklin
AU  - Chengjie Xiong
AU  - Guoqiao Wang
AU  - Jinbin Xu
AU  - Huifangjie Farsad
AU  - Catherine J. Mummery
AU  - Colin L. Masters
AU  - Raquel Sanchez-Valle
AU  - Mario Masellis
AU  - Ging-Yuek Robin Hsiung
AU  - Serge Guthier
AU  - James J. Lah
AU  - Sarah B. Berman
AU  - Erik D. Roberson
AU  - Ghulam Surti
AU  - Lawrence S. Honig
AU  - Roger Clarnette
AU  - Paolo Vitali
AU  - John Ringman
AU  - Thomas D. Bird
AU  - William S. Brooks
AU  - Nick C. Fox
AU  - Kazushi Suzuki
AU  - Sandra E. Black
AU  - Johannes Levin
AU  - Martin R. Farlow
AU  - Jasmeer Chhatwal
AU  - Neelum T. Aggarwal
AU  - Mathias Jucker
AU  - Matthew P. Frosch
AU  - Julia K. Kofler
AU  - Charles White
AU  - C. Dirk Keene
AU  - Jie Chen
AU  - Jonathan Glass
AU  - Marla Gearing
AU  - Natalie S. Ryan
AU  - David Aguillón
AU  - Charlene Supnet-Bell
AU  - Brian A. Gordon
AU  - Tammie L.S. Benzinger
AU  - John Sims
AU  - Roy Yaari
AU  - Tobias Bittner
AU  - Gregory Klein
AU  - Paul Delmar
AU  - John C Morris
AU  - Jorge Llibre-Guerra
AU  - David B. Clifford
AU  - Celeste M. Karch
AU  - Eric McDade
AU  - Richard J. Perrin
AU  - Randall J. Bateman
AU  - Unknown
AU  - Unknown
PY  - 2026
DO  - 10.64898/2026.09.22.26363432
UR  - https://doi.org/10.64898/2026.09.22.26363432
ER  -

APA

Mukherjee, S., Barthélemy, N. R., Atri, T., Li, Y., Yen, D., He, Y., Coyle, R., Ovod, V., Franklin, E. E., Xiong, C., Wang, G., Xu, J., Farsad, H., Mummery, C. J., Masters, C. L., Sanchez-Valle, R., Masellis, M., Hsiung, G. R., Guthier, S., Lah, J. J., Berman, S. B., Roberson, E. D., Surti, G., Honig, L. S., Clarnette, R., Vitali, P., Ringman, J., Bird, T. D., Brooks, W. S., Fox, N. C., Suzuki, K., Black, S. E., Levin, J., Farlow, M. R., Chhatwal, J., Aggarwal, N. T., Jucker, M., Frosch, M. P., Kofler, J. K., White, C., Keene, C. D., Chen, J., Glass, J., Gearing, M., Ryan, N. S., Aguillón, D., Supnet-Bell, C., Gordon, B. A., Benzinger, T. L., Sims, J., Yaari, R., Bittner, T., Klein, G., Delmar, P., Morris, J. C., Llibre-Guerra, J., Clifford, D. B., Karch, C. M., McDade, E., Perrin, R. J., Bateman, R. J., Unknown, & Unknown (2026). Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease. https://doi.org/10.64898/2026.09.22.26363432

Source records

crossref · retrieved 2026-11-09T15:39:06.921Z